Liangtu Liang

Liangtu Liang


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 April 2026 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ZHZhilan Huang
Zhilan Huang
TXTingyi Xie
Tingyi Xie
MTMingwen Tang
Mingwen Tang
ZCZhuni Chen
Zhuni Chen
DJDan Jia
Dan Jia
WXWei Xie
Wei Xie
Background: Pulmonary fibrosis is a severe chronic lung disease whose prevalence has been rising in recent years, representing one of the major respiratory health challenges globally in the 21st century. The burden of this disease on the elderly population is garnering growing attention, particularly as the global population ages. The Global Burden of Disease (GBD) study has provided valuable insights; however, systematic analyses focused on this condition remain limited. To date, few studies have specifically examined interstitial lung disease and pulmonary sarcoidosis among individuals aged 55 years and older. This study aims to conduct a comprehensive analysis of burden trends from 1990 to 2021 for those aged 55 and above and to project future trends up to 2035. Methods: Our approach utilizes the estimation of four broad component measures: incidence, prevalence, death and Disability-Adjusted Life Years (DALYs), using data on ILD&PS from the Global Burden of Disease (GBD) 2021 database. Joinpoint regression models were applied to calculate the average annual percentage change (AAPC) in order to analyze temporal trends in disease burden and to identify years with significant trend shifts. Analyses were further stratified by age, sex, region, country, and Sociodemographic Index (SDI). Additionally, a Bayesian age-period-cohort (BAPC) model was used to project future disease burden trends. Results: Between 1990 and 2021, significant increases were observed in incidence, DALYs, and death rates for ILD&PS (AAPC incidence = 1.09, 95% CI: 1.04 to 1.15; AAPC DALYs = 1.10, 95% CI: 0.97 to 1.23; AAPC death = 1.65, 95% CI: 1.47 to 1.83). In 2021, the total number of incident cases reached 284,887 (95% UI 248,300–328,800), with the highest incidence rates observed in Andean Latin America. Across age- and sex-specific analyses, global burden trends were similar, though males consistently exhibited higher rates than females. The oldest age group (95 + years) had the highest incidence and DALYs rates among all age strata. Furthermore, incidence rates increased most markedly in high-SDI regions, showing a strong positive correlation between SDI and incidence. Bayesian age–period–cohort (BAPC) analyses indicated that while prevalence rates are projected to decline slightly, incidence rates are expected to continue rising. Both males and females showed a dip then rise in prevalence trends, but the increase was more pronounced among females. In 2035, the highest number of incident cases is projected to occur in the 65–69 age group, whereas the highest incidence rate is predicted in the 95 + age group. Conclusions: A concerning upward trend in incidence, DALYs, and deaths related to ILD&PS was observed in the global population aged 55 years and older, particularly among females. To our knowledge, this is the first study to comprehensively analyze the burden of ILD&PS in this age group from 1990 to 2021. Our findings on epidemiological trends and their variations across geography, SDI, age, and sex can inform policy-makers in designing targeted strategies to mitigate the anticipated rise in disease burden.

1 July 2016 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
SYShanshan Yin
Shanshan Yin
SZShuangwei Zhang
Shuangwei Zhang
GTGuoyong Tong
Guoyong Tong
LDLihong Deng
Lihong Deng
LLLiangtu Liang
Liangtu Liang
JZJun Zhang
Jun Zhang

22 November 2025 in Journal of Genetic Engineering and Biotechnology
Verified
Journal Article
Open access
KLKeying Li
Keying Li
LLLiangtu Liang
Liangtu Liang
MLMinfang Li
Minfang Li
XSXuxin Sun
Xuxin Sun
WXWei Xie
Wei Xie
SCSheng Chen
Sheng Chen
Chronic obstructive pulmonary disease (COPD) andHelicobacter pylori (H. pylori) infection may share common pathogenic mechanisms, yet their molecular and cellular interactions remain poorly defined. Public datasets for COPD and H. pyloriinfection were retrieved from the Gene Expression Omnibus (GEO) database. Differentially expressed genes (DEGs) were identified, followed by weighted gene co-expression network analysis (WGCNA) to define disease-associated modules. Overlapping genes underwent functional enrichment via Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG). Support vector machine-recursive feature elimination (SVM-RFE) was analyzedto identify hub genes. Gene set enrichment analysis (GSEA), receiver operating characteristic (ROC) curve validation, and immune infiltration analysis using CIBERSORT were performed. Single-cell RNA sequencing (scRNA-seq) and cell-cell communication analysis were further applied to characterize hub gene expression and intercellular interactions. Integrative analysis identified 100 co-expressed genes, which were associated with cytokine-receptor interaction, TNF signaling, and chemokine-mediated signaling.SVM-RFE highlightedCCR1andCCL19as shared genes, validated in external cohorts, with GSEA indicating involvement in immune and inflammatory signaling.ROC curves confirmed robust diagnostic performance.Immune infiltration analysis showed macrophages M0 were consistently elevated in COPD and H. pylori infection; CCR1 and CCL19 are associated with multiple immune cell types. Single-cell analysis revealed hub genes are primarily expressed in macrophages and fibroblasts, potentially modulating pathogenesis via interactions between immune and signaling pathways. CCR1 and CCL19 are shared genes linking COPD and H. pylori infetion, which regulate immune homeostasis and inflammatory signalingvia influencing macrophagesand fibroblasts. These findings offered new ideas for molecular mechanisms and integrated therapeutic interventionsin COPD and H. pylori infetion.